Page last updated: 2024-09-03

6-methylene-4-pregnene-3,20-dione and androstenedione

6-methylene-4-pregnene-3,20-dione has been researched along with androstenedione in 1 studies

Compound Research Comparison

Studies
(6-methylene-4-pregnene-3,20-dione)
Trials
(6-methylene-4-pregnene-3,20-dione)
Recent Studies (post-2010)
(6-methylene-4-pregnene-3,20-dione)
Studies
(androstenedione)
Trials
(androstenedione)
Recent Studies (post-2010) (androstenedione)
20007,175377960

Protein Interaction Comparison

ProteinTaxonomy6-methylene-4-pregnene-3,20-dione (IC50)androstenedione (IC50)
CholinesteraseHomo sapiens (human)1.55
AromataseHomo sapiens (human)0.3
Androgen receptorRattus norvegicus (Norway rat)0.6761
Testosterone 17-beta-dehydrogenase 3Homo sapiens (human)0.6826

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iguchi, T; Petrow, V; Takasugi, N; Todoroki, R1

Other Studies

1 other study(ies) available for 6-methylene-4-pregnene-3,20-dione and androstenedione

ArticleYear
The effects of an aromatase inhibitor and a 5 alpha-reductase inhibitor upon the occurrence of polyovular follicles, persistent anovulation, and permanent vaginal stratification in mice treated neonatally with testosterone.
    Biology of reproduction, 1988, Volume: 39, Issue:3

    Topics: 5-alpha Reductase Inhibitors; Androstenedione; Animals; Anovulation; Aromatase Inhibitors; Epithelium; Female; Mice; Mice, Inbred C57BL; Ovarian Follicle; Progesterone; Testosterone; Vagina

1988